These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16722659)

  • 1. Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors.
    Kumar A; Ye G; Wang Y; Lin X; Sun G; Parang K
    J Med Chem; 2006 Jun; 49(11):3395-401. PubMed ID: 16722659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
    Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
    J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of efficient pentapeptide substrates for the tyrosine kinase pp60c-src.
    Nair SA; Kim MH; Warren SD; Choi S; Songyang Z; Cantley LC; Hangauer DG
    J Med Chem; 1995 Oct; 38(21):4276-83. PubMed ID: 7473555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors.
    Prabhu NV; Siddiqui SA; McMurray JS; Pettitt BM
    Biopolymers; 2001 Sep; 59(3):167-79. PubMed ID: 11391566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding.
    Davidson JP; Lubman O; Rose T; Waksman G; Martin SF
    J Am Chem Soc; 2002 Jan; 124(2):205-15. PubMed ID: 11782172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines.
    Tian G; Cory M; Smith AA; Knight WB
    Biochemistry; 2001 Jun; 40(24):7084-91. PubMed ID: 11401553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pp60c-Src inhibitor PP1 is non-competitive against ATP.
    Karni R; Mizrachi S; Reiss-Sklan E; Gazit A; Livnah O; Levitzki A
    FEBS Lett; 2003 Feb; 537(1-3):47-52. PubMed ID: 12606029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and activity of novel 5-substituted pyrrolo[2,3-d]pyrimidine analogues as pp60(c-Src) tyrosine kinase inhibitors.
    Olgen S; Isgör YG; Coban T
    Arch Pharm (Weinheim); 2008 Feb; 341(2):113-20. PubMed ID: 18214841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 3-phenylpyrazolo[3,4-d]pyrimidine-peptide conjugates as Src kinase inhibitors.
    Kumar A; Wang Y; Lin X; Sun G; Parang K
    ChemMedChem; 2007 Sep; 2(9):1346-60. PubMed ID: 17530729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor.
    Ramdas L; Obeyesekere NU; Sun G; McMurray JS; Budde RJ
    J Pept Res; 1999 May; 53(5):569-77. PubMed ID: 10424353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of potent and specific peptide inhibitors of p60c-src protein tyrosine kinase using pseudosubstrate-based inhibitor design approach.
    Kamath JR; Liu R; Enstrom AM; Lou Q; Lam KS
    J Pept Res; 2003 Dec; 62(6):260-8. PubMed ID: 14632929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear and cyclic synthetic peptides related to the main autophosphorylation site of the Src tyrosine kinases as substrates and inhibitors of Lyn.
    Ruzza P; Calderan A; Filippi B; Biondi B; Deana AD; Cesaro L; Pinna LA; Borin G
    Int J Pept Protein Res; 1995 Jun; 45(6):529-39. PubMed ID: 7558583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent pseudosubstrate-based peptide inhibitors for p60(c-src) protein tyrosine kinase.
    Lou Q; Leftwich ME; McKay RT; Salmon SE; Rychetsky L; Lam KS
    Cancer Res; 1997 May; 57(10):1877-81. PubMed ID: 9157979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
    Burke TR; Barchi JJ; George C; Wolf G; Shoelson SE; Yan X
    J Med Chem; 1995 Apr; 38(8):1386-96. PubMed ID: 7537333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.
    Tiwari R; Brown A; Narramaneni S; Sun G; Parang K
    Biochimie; 2010 Sep; 92(9):1153-63. PubMed ID: 20109515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 1: hydroxynaphthalene derivatives.
    Marsilje TH; Milkiewicz KL; Hangauer DG
    Bioorg Med Chem Lett; 2000 Mar; 10(5):477-81. PubMed ID: 10743952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.